Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Article Abstract:

A study was conducted to evaluate the incidence, predictors, and clinical outcome of stent thrombosis after implantation of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice. The result showed that the cumulative incidence of stent thrombosis 9 months after successful drug-eluting stent implantation in consecutive 'real world' patients was substantially higher than the rate reported in clinical trials.

Author: Schmidt, Thomas, Bonizzoni, Erminio, Lakovou, Ioannis, Lei Ge; Carlino, Mauro, Sangiorgi, Giuseppe M., Stankovic, Goran, Grube, Eberhand, Airoldi, Flavio, Colombo, Antonio, Montorfano, Matteo, Michev, Lassen, Corvaja, Nicola, Gerckens, Ulrich
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Thrombosis, Stent (Surgery), Stents, Blood clot

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions

Article Abstract:

A study to compare the safety and efficacy of sirolimus-eluting stent and the paclitaxel-eluting stent systems in multicenter, randomized clinical trial in patients with de novo coronary artery lesions is conducted. No differences in the rates of binary restenosis or major adverse cardiac events were found.

Author: Serruys, Patrick, Morice, Marie-Claude, Meier, Bernhard, Colombo, Antonio, Tamburino, Corrado, Guagliumi, Giulio, Sousa, Eduardo, Stoll, Hans-Peter
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Comparative analysis, Paclitaxel, Sirolimus

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

Article Abstract:

A study to determine 1-year ischemic or mortality outcomes for patients in the ACUITY trial is presented. Results conclude with no significant difference in mortality rates among patients with moderate and high-risk ACS undergoing invasive treatment.

Author: White, Harvey D., Pocock, Stuart J., Lincoff, A. Michael, Ware, James H., Moses, Jeffrey W., Cox, David A., Bertrand, Michel E., Feit, Frederick, Mehran, Roxana, Colombo, Antonio, Fahy, Martin, Stone,Gregg W., Ohman, F. Magnus, McLaurin, Brent T., Manoukian, Steven W., Clayton, Tim C.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Blood Clot Dissolvers, Care and treatment, Fibrinolytic agents, Thrombolytic drugs, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Usage, Patient outcomes, Drug therapy, Coronary heart disease
Similar abstracts:
  • Abstracts: Incidence and predictors of prolonged urinary retention after TVT with and without concurrent prolapse surgery
  • Abstracts: Gynecologic and obstetric aspects of Gaucher's disease: a survey of 53 patients. Pregnancies in Gaucher disease: A 5-year study
  • Abstracts: Identifying the development needs of community matrons. Management and outcome of a preferred place of care pilot
  • Abstracts: Will care checks raise standards? An overview of the new resuscitation guidelines. New guideline on preventing and managing pressure ulcers
  • Abstracts: Old approach yields new antibiotic. The business of developing antibacterials. Multi-targeting by monotherapeutic antibacterials
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.